Some studies demonstrated increased slow-wave sleep following DSIP administration, whereas others reported no significant differences compared with placebo
Programme length varies depending on individual objectives, physician recommendations, and overall treatment planning
As of July 26, 2026, 21 CFR 216.23 lists six substances that can be used through this pathway: Brilliant Blue G, cantharidin for topical use only, diphenylcyclopropenone for topical use only, N-acetyl-D-glucosamine for topical use only, squaric acid dibutyl ester for topical use only, and thymol iodide for topical use only
Here, we will provide an overview of the cellular pathways by which myeloid cells and innate lymphocytes interact with endothelial cells in the TME and discuss potential implications of such interactions for anti-cancer treatments
They can be useful when an approved drug cannot meet a particular patients needs, but they also carry additional risks